Search

Search Results
Results 501 - 510 of 805 for Male breast cancer
  • Finasteride Viatris 5
    Drug - 9 Jan 2026
    Consumer Medicine Information (CMI) about Finasteride Viatris 5 intended for persons living in Australia.
  • Pathology AI models show demographic bias in cancer diagnosis
    News - 16 Dec 2025
    Pathology has long been the cornerstone of cancer diagnosis and treatment. A pathologist carefully examines an ultrathin slice of human tissue under a microscope for clues that indicate the presence,...
  • DBL Vincristine Sulfate Injection
    Drug - 10 Nov 2025
    Consumer Medicine Information (CMI) about DBL Vincristine Sulfate Injection intended for persons living in Australia.
  • Itovebi
    Drug - 20 Oct 2025
    Consumer Medicine Information (CMI) about Itovebi intended for persons living in Australia.
  • DBL Docetaxel
    Drug - 3 Oct 2025
    Consumer Medicine Information (CMI) about DBL Docetaxel intended for persons living in Australia.
  • Adriamycin
    Drug - 25 Sep 2025
    Consumer Medicine Information (CMI) about Adriamycin intended for persons living in Australia.
  • Truqap
    Drug - 15 Sep 2025
    Consumer Medicine Information (CMI) about Truqap intended for persons living in Australia.
  • Lynparza Tablets
    Drug - 27 Mar 2025
    Consumer Medicine Information (CMI) about Lynparza Tablets intended for persons living in Australia.
  • How different types of bread impact cancer risk
    News - 20 Nov 2024
    Researchers find bread consumption is not linked to cancer risk, with whole-grain bread potentially reducing colorectal cancer and total cancer mortality.
  • Older adults face higher CVD risk post-cancer treatment
    News - 25 Sep 2024
    Older adults treated for cancer face twice the risk of developing cardiovascular diseases compared to those without cancer. The highest risks are seen in patients with metastatic, hematologic, and...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback